''Omicron or not, we have reason to believe that the days of...
Category:
Pandemic
Latest
Gap between 2nd Covid shot and booster likely to be 9-12 months: Report
The nitty-gritty of the gaps for the vaccines currently being used...
World economy now set to surpass $100 Trillion in 2022, India to become 3rd largest by 2031
British consultancy Cebr predicts India looks set to overtake...
Govt asks to states to take on preventive measures to curb the spread of Covid in rural India
To provide real-time information on availability of testing/vaccination centers, doctors, hospital beds etc. to rural citizens, the Ministry has advised state governments to leverage available IT infrastructure like Panchayat offices, Schools, Common Service Centers etc.
Eli Lilly signs deals to boost supply of COVID-19 treatment in India
The three Indian drugmakers – Cipla Ltd , Lupin Ltd and Sun Pharma – will collaborate with U.S.-based Lilly to help make and sell baricitinib in India.The agreements will bolster India’s arsenal of drugs to battle its catastrophic second wave of the pandemic, which has led to an acute shortage of coronavirus medicines including remdesivir and tocilizumab.
Total vehicle registrations in India slips 30 pc to 1,52,71,519 units in 2020-21: FADA
”Recovery hence looks to take a longer time when compared to recovery which came after the first wave. The only ray of hope lies on the on time arrival monsoon which is likely to enter India through the southern coast around June 1,” it said.
Investors brace for market fallout as most of India’s states lock down
“Markets will correct if the government announces a nationwide lockdown,” said Naveen Kulkarni, chief investment officer at Axis Securities Ltd. “However, the critical factor will be the duration. The longer any lockdown is, the greater will be the correction.”
Budget heading for vaccination expenditure does not inhibit Centre from using funds: FinMin
Currently, COVID-19 vaccines are being provided free of cost by the Centre to those who are 45 years of age and above and to all frontline workers.
The Centre has so far provided more than 17.56 crore vaccine doses to states/ UTs free of cost.
Universal pricing system for COVID-treatment introduced in pvt hospitals: Kerala govt tells HC
The government said charges for various treatments, consumables, medicines, doctors and nursing should be made known to the public and will be monitored by the secretary Clinical Establishment Act.
”If any hospital is found to be charging more than the rates… they shall be levied a penalty which shall be ten times the additional charges by the concerned DMO(H),” it said.
Last week, the high court had directed the state government to take steps to introduce a uniform tariff rate for COVID-19 treatment at private hospitals.
Underwriters puzzle over how to make pandemics insurable again
U.S. company SpottedRisk has devised a model built on years of data on the political and economic environment of film locations in 150 countries, as well as a year’s COVID-19 shutdown data, to come up with a pricing mechanism to cover the risk of production stopping due to the pandemic.
Britain, the European Union and the United States are all looking at arrangements in which cover from commercial insurers would be backed by government reinsurance schemes. Such schemes could be less costly than business bailouts but the process of developing them is slow, as governments grapple with the problems at hand.
Europe dares to reopen as 200 millionth vaccine dose delivered
With 200 million vaccine doses delivered, the European Union is on track to achieve its goal of inoculating 70% of its adult population by summer, Commission President Ursula von der Leyen tweeted on Sunday.
Insurers can’t deny Carona covers to customers: IRDAI
All insurers, as applicable, are advised to continue offering Corona Kavach and Corona Rakshak Policies and also to renew these policies, said the IRDAI.
Max Bupa settles over Rs 150 cr Covid claims so far; closely watching impact on premium: Official
”As a company, we decided not to go for a revision in premium last year to offer some relief to our customers as Covid had impacted most of people economically as well. We are closely monitoring the situation as far as this second wave is concerned and adopting a wait and watch approach in terms of impact on premiums,” Mishra said.